Key result
Levosimendan infusion without an initial bolus successfully corrected low cardiac output and resolved electrical storm in two patients with cardiogenic shock, without pro-arrhythmic effects.
Why the study?
Does levosimendan infusion without a bolus dose safely improve hemodynamics without pro-arrhythmic effects in patients with cardiogenic shock and electrical storm?
Case Report (n=2)
Does levosimendan infusion without a bolus dose safely improve hemodynamics without pro-arrhythmic effects in patients with cardiogenic shock and electrical storm?
Answers are grounded in this paper and cite their sources.
Levosimendan infusion without a bolus dose may safely correct hemodynamics in cardiogenic shock complicated by electrical storm without inducing pro-arrhythmic effects.
Background: Levosimendan, an inotrope and vasodilator, is a second-line treatment for cardiogenic shock. One of its main advantages is its prolonged effect compared to Dobutamine.
No takes yet. Share an insight, caveat, or question.
Rougé et al. (2021) conducted a case report in Cardiogenic shock with electrical storm (n=2). Levosimendan was evaluated on Correction of low cardiac output and resolution of arrhythmia. Levosimendan infusion without an initial bolus successfully corrected low cardiac output and resolved electrical storm in two patients with cardiogenic shock, without pro-arrhythmic effects.
Synapse has enriched 10 related papers. Consider them for comparative context: